Email
Password
Remember meForgot password?
    Log in with Twitter
Press Release

Jan 6, 2020 18:45 UTC

Global Structural Heart Disease Treatment Devices Market 2020-2024| Evolving Opportunities with Abbott Laboratories and Braile Biomédica | Technavio

LONDON--(Business Wire)--Technavio has been monitoring the global structural heart disease treatment devices market since 2018 and the market is poised to grow by USD 5.61 billion during 2020-2024 at a CAGR of over 10% during the forecast period. Request Free Sample Pages

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200106005666/en/

Technavio has announced its latest market research report titled global structural heart disease tre ...

Technavio has announced its latest market research report titled global structural heart disease treatment devices market 2020-2024. (Graphic: Business Wire)

Read the 165-page research report with TOC on "Structural Heart Disease Treatment Devices Market Analysis Report by geography (Asia, Europe, North America, and ROW), by End-users (Hospitals and clinics and ASCs), by Product (Replacement devices and Repair devices), and Segment Forecasts, 2020-2024".

https://www.technavio.com/report/structural-heart-disease-treatment-devices-market-industry-analysis

The increasing prevalence of structural heart diseases and technological innovations in structural heart disease treatment are anticipated to boost the growth of the market.

The prevalence of structural heart diseases such as aortic stenosis, heart valve disease, valvular stenosis, and congenital heart defects is increasing around the globe. According to the NIH, in 2019, about 10% of the population aged 75 and above were found with degenerative abnormalities associated with severe aortic stenosis and mitral and tricuspid regurgitation. The increased life expectancy in the elderly population is increasing the prevalence of heart valve diseases such as CHD. This will increase the demand for structural heart disease treatment devices and drive market growth during the forecast period.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Structural Heart Disease Treatment Devices Market Companies:

Abbott Laboratories

Abbott Laboratories is headquartered in the US and operates the business under various segments such as Established Pharmaceuticals, Nutritionals, Diagnostics, and Cardiovascular and Neuromodulation. The company offers AMPLATZER PFO Occluder, MitraClip, and Trifecta GT aortic valve.

Becton, Dickinson and Co.

Becton, Dickinson and Co. is headquartered in the US and offers products through the following business units: Medical, Life Sciences, and Interventional. The company offers TRUE Dilatation balloon valvuloplasty catheters and TRUE Flow valvuloplasty perfusion catheter.

Boston Scientific Corp.

Boston Scientific Corp. is headquartered in the US and operates under various business segments, namely MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers WATCHMAN and LOTUS Edge Aortic Valve System.

Braile Biomédica

Braile Biomédica is headquartered in Brazil and offers products through the following business segments: Biological, Cardiovascular, Electromedicals, Endovascular, Oncology, and Transcatheter. The company offers Malleable Valve Annuloplasty Ring and Organic Valve Prosthesis Porcine.

CryoLife Inc.

CryoLife Inc. is headquartered in the US and offers products through the following two business segments: Medical devices and Preservation services. The company offers On-X Heart Valve and CryoValve SG Pulmonary Human Heart Valves.

Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform

Structural Heart Disease Treatment Devices Product Outlook (Revenue, USD Million, 2020-2024)

  • Replacement devices
  • Repair devices

Structural Heart Disease Treatment Devices Regional Outlook (Revenue, USD Million, 2020-2024)

  • Asia
  • Europe
  • North America
  • ROW

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

Related Reports on Health Care include:

Artificial Heart Market – Global Artificial Heart Market by product (VAD and TAH) and geography (Asia, Europe, North America, and ROW).

Heart Defect Closure Devices Market – Global Heart Defect Closure Devices Market by product (LAA closure devices, PFO closure devices, ASD closure devices, and other heart defect closure devices) and geography (Asia, Europe, North America, and ROW).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: https://www.technavio.com

Latest News
Top News